Company intelligence / Profile preview

Onbone

Ownership: Private
Development stage: Other

Overview

OncoBone Ventures develops novel immunotherapies for incurable bone metastases using proprietary biomarker discovery and osteoimmunology platforms. The company collaborates internationally to evaluate partner assets in preclinical models. No clinical results reported yet.

Therapeutic areas: Oncology
Modalities: ImmunotherapySmall moleculeBiologic
Industry: Biotech

Partnerships

Development Center for Biotechnology (Taiwan)

Beyond the preview

Go deeper on Onbone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onbone.

Explore the full profile